» Articles » PMID: 19129281

Pleural Plaques and Asbestosis: Dose- and Time-response Relationships Based on HRCT Data

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2009 Jan 9
PMID 19129281
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Most studies on asbestos-related diseases are based on chest radiographs, and dose-response relationships are still controversial. The aim of this study was to describe the most relevant parameters of asbestos exposure linked to pleural plaques and asbestosis diagnosed by high-resolution computed tomography (HRCT). A large screening programme including systematic HRCT examinations was organised from 2003 to 2005 in France for formerly asbestos-exposed workers. The time since first exposure (TSFE), level, duration and cumulative exposure to asbestos were used in adjusted unconditional logistic regression to model the relationships of the two diseases. Analysis of a population of 5,545 subjects demonstrated that TSFE (p<0.0001) and cumulative exposure (p = 0.02) (or level, depending on the models used), were independently associated with the frequency of pleural plaques. Only cumulative exposure (p<0.0001) or level of exposure (p = 0.02) were significantly associated with asbestosis. All trend tests were significant for these parameters. To date and to our knowledge, this study is the largest programme based on HRCT for the screening of asbestos-exposed subjects. Both time-response and dose-response relationships were demonstrated for pleural plaques, while only dose-response relationships were demonstrated for asbestosis. These parameters must be included in the definition of high-risk populations for HRCT-based screening programmes.

Citing Articles

Occupational exposure to ultrafine particles and lung cancer in a population exposed to asbestos.

Rostello C, Gramond C, Audignon S, Thaon I, Brochard P, Benoist J BMC Public Health. 2025; 25(1):784.

PMID: 40011848 PMC: 11863659. DOI: 10.1186/s12889-025-22038-2.


Asbestos exposure, pleural plaques and digestive cancers.

Clin B, Gramond C, Delva F, Andujar P, Thaon I, Brochard P BMC Public Health. 2025; 25(1):686.

PMID: 39972315 PMC: 11841182. DOI: 10.1186/s12889-025-21969-0.


Relationships between asbestos exposure and pleural plaques: dose and time effects using fractional polynomials.

Menant M, Benlala I, Thaon I, Andujar P, Julia B, Brochard P Occup Environ Med. 2024; 81(6):313-319.

PMID: 38925963 PMC: 11287532. DOI: 10.1136/oemed-2023-108975.


Interstitial Lung Disease and Progressive Pulmonary Fibrosis: a World Trade Center Cohort 20-Year Longitudinal Study.

Cleven K, Zeig-Owens R, Mueller A, Vaeth B, Hall C, Choi J Lung. 2024; 202(3):257-267.

PMID: 38713420 PMC: 11142940. DOI: 10.1007/s00408-024-00697-z.


Artificial Intelligence-based Quantification of Pleural Plaque Volume and Association With Lung Function in Asbestos-exposed Patients.

Groot Lipman K, Boellaard T, de Gooijer C, Bogveradze N, Hong E, Landolfi F J Thorac Imaging. 2023; 39(3):165-172.

PMID: 37905941 PMC: 11027965. DOI: 10.1097/RTI.0000000000000759.